Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Analysts

<< Previous

Bullboard Posts

Next >>

Comment by PLITheOneon Apr 16, 2021 10:37am

31 Views

Post# 33010550

RE:Analysts

Stickyscamo knows how this works

PLITheOne wrote:
Remember what Stickyscamo said, analysts manipulate stocks Echelon, Bloom Burton and Piper are all in bed with Thomson's!! Not to be believed for a minute. Accual target $2.00!!!

PLITheOne wrote:LOL Stickyscamo! All you have left now for analysts are pinons! ROFL :)))

Newcamo - (6/10/2019 3:11:02 PM)
RE:RE:L’analyste de la RBC cesse sa couverture - Les Affaires
these analysts are more often than not pions that try to manipulate sp to their benefit. Remember TD? Weeks later they were buying, they gat burned like the rest of us, but they loaded up....and are very active even now... it's all a game, money game.